These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24148247)

  • 1. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma.
    Liu M; Wang J; Huang H; Hou J; Zhang B; Wang A
    Biochem Biophys Res Commun; 2013 Nov; 441(2):364-70. PubMed ID: 24148247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
    Peng F; Zhang H; Du Y; Tan P
    Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
    Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
    Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
    Wang X; Guo H; Yao B; Helms J
    Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-940 inhibits migration and invasion of tongue squamous cell carcinoma via regulatingCXCR2/NF-κB system-mediated epithelial-mesenchymal transition.
    Ma T; Zhao Z; Wang Z; Wang C; Zhang L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1359-1369. PubMed ID: 31214736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling.
    Yang ZH; Li J; Chen WZ; Kong FS
    Cell Biochem Funct; 2020 Oct; 38(7):943-954. PubMed ID: 32325539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.
    Li D; Liu K; Li Z; Wang J; Wang X
    Cell Adh Migr; 2018 May; 12(3):236-246. PubMed ID: 29130787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin.
    Zhu X; Shen H; Yin X; Long L; Xie C; Liu Y; Hui L; Lin X; Fang Y; Cao Y; Xu Y; Li M; Xu W; Li Y
    Oncogene; 2016 Jan; 35(3):323-32. PubMed ID: 25867064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNHG1/miR-194-5p/MTFR1 Axis Promotes TGFβ1-Induced EMT, Migration and Invasion of Tongue Squamous Cell Carcinoma Cells.
    Jia Y; Chen X; Zhao D; Ma S
    Mol Biotechnol; 2022 Jul; 64(7):780-790. PubMed ID: 35107755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis.
    Liu M; Liu Q; Fan S; Su F; Jiang C; Cai G; Wang Y; Liao G; Lei X; Chen W; Bi J; Cheng W; Zhao L; Ruan Y; Li J
    Cell Death Dis; 2021 Feb; 12(2):144. PubMed ID: 33542221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.
    Lin XJ; He CL; Sun T; Duan XJ; Sun Y; Xiong SJ
    Int J Mol Med; 2017 Jul; 40(1):83-89. PubMed ID: 28535002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-488 inhibits tongue squamous carcinoma cell invasion and EMT by directly targeting ATF3.
    Shi B; Yan W; Liu G; Guo Y
    Cell Mol Biol Lett; 2018; 23():28. PubMed ID: 29946339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
    Jiao J; Zhao X; Liang Y; Tang D; Pan C
    Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
    Liu W; Zhang B; Xu N; Wang MJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
    Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
    Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.